Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ICATIBANT ACETATE, with a corresponding US DMF Number 34450.
Remarkably, this DMF maintains an Active status since its submission on February 06, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 13, 2020, and payment made on December 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II